New oral anti-angiogenic agent slows metastatic CRC progressionJanuary 21, 2015GastroenterologyGastrointestinal Cancer
Preoperative hepatic, regional arterial chemo nets better outcomes in early CRCJanuary 20, 2015GastroenterologyGastrointestinal Cancer
Add cetuximab for metastatic RAS wild-type CRCJanuary 19, 2015GastroenterologyGastrointestinal Cancer
New kinase inhibitor is highly active in MET-amplified gastric cancerJanuary 19, 2015GastroenterologyGastrointestinal Cancer
Vitamin D appears protective in patients with metastatic colorectal cancerJanuary 17, 2015GastroenterologyGastrointestinal Cancer
Stage IV CRC survival rates up, resection rates downJanuary 15, 2015GastroenterologyGastrointestinal Cancer
Ramucirumab may expand treatment options for metastatic colorectal cancerJanuary 13, 2015GastroenterologyGastrointestinal Cancer
Skipping surgery is an option for some patients with rectal cancerJanuary 13, 2015GastroenterologyGastrointestinal Cancer
Outcomes of stage III colon cancer appear better for aspirin, COX-2 inhibitor usersJanuary 13, 2015GastroenterologyGastrointestinal Cancer
TRIBE update: FOLFOXIRI-bevacizumab boosts survival in metastatic CRCJanuary 12, 2015GastroenterologyGastrointestinal Cancer
Microbiota organization influences colorectal cancersJanuary 12, 2015GastroenterologyGastrointestinal Cancer
Stage, lymph node status should drive gastric cancer treatment decisionsJanuary 6, 2015GastroenterologyRare DiseasesGastrointestinal Cancer
Identification of subtypes, mutations in CRC and colon cancer greatly increases survival ratesJanuary 1, 2015GastroenterologyGastrointestinal Cancer
FDA approves lanreotide for GEP-NETs after priority reviewDecember 16, 2014GastroenterologyGastrointestinal Cancer
New agent extends progression-free survival in advanced pancreatic cancerDecember 15, 2014GastroenterologyGastrointestinal Cancer
